查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
人造器官與仿生植入物市場：現況分析與預測（2023-2030）
市場調查報告書
商品編碼
1408700

人造器官與仿生植入物市場：現況分析與預測（2023-2030）

Artificial Organs & Bionic Implants Market: Current Analysis and Forecast (2023-2030)
出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 144 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

2022年，人造器官和仿生植入物市場價值達350億美元，預計2023年至2030年複合年增長率約10%。

按類型劃分，市場分為人造器官和仿生植入物。到 2022 年，人造器官類別將佔據重要的市場份額。該細分市場的成長主要是由於對腎臟、心臟、肺和肝臟移植的需求不斷增加。例如，根據器官採購和移植網絡的數據，美國總共進行了 24,669 例腎臟移植、9,236 例肝臟移植和 3,817 例心臟移植。在美國，腎臟移植的平均等待時間約為 5 年。因此，製造商正在透過開發生物製氧器、人工胰臟和穿戴式人工腎臟等創新解決方案來應對滿足未滿足需求的挑戰。

依技術劃分，市場分為機械市場和電子市場。其中，機械類將在2022年佔據較大的市場份額。機械人造器官可用於幫助患有先天性疾病或出生缺陷的人。例如，人造器官可以幫助失去雙手的人完成日常任務並過著更獨立的生活。

為了更了解該產業的市場採用情況，市場包括北美（美國、加拿大、北美其他地區）、歐洲（德國、英國、法國、義大利、西班牙、歐洲其他地區）、亞太地區（中國、日本、印度）、韓國、澳洲以及亞太地區其他地區）以及世界其他地區。到 2022 年，北美將在周邊脈搏血氧儀市場佔據壓倒性份額。每個國家成熟的醫療基礎設施和不斷增加的醫療支出是推動北美市場成長的主要因素。

目錄

第一章 市場介紹

  • 市場定義
  • 主要目標
  • 利益相關者
  • 限制

第二章 研究方法或假設

  • 調查過程
  • 調查方法
  • 受訪者簡介

第三章市場總結

第 4 章執行摘要

第五章 全球人工器官及仿生植入物市場

第六章 COVID-19 對市場的影響

第七章 全球人造器官和仿生植入物市場收入（2020-2030）

第 8 章按類型劃分的市場洞察

  • 人造器官
    • 人工心臟
    • 人工腎
    • 人工肺
    • 人工耳蝸
    • 其他器官類型
  • 仿生學
    • 視覺仿生學
    • 耳仿生學
    • 骨科仿生學
    • 其他仿生學

第九章技術市場洞察

  • 機械的
  • 電子的

第10章按地區劃分的市場洞察

  • 北美
    • 美國
    • 加拿大
    • 北美其他地區
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 世界其他地區

第十一章：人造器官與仿生植入物市場動態

  • 市場驅動力
  • 市場挑戰
  • 影響分析

第十二章人造器官與仿生植入物市場機會

第十三章 人工器官與仿生植入物市場趨勢

第十四章需求面和供給面分析

  • 需求面分析
  • 供給側分析

第十五章價值鏈分析

第16章 競爭場景

  • 競爭格局
    • 波特五力分析

第十七章公司簡介

  • ABIOMED
  • Berlin Heart
  • Zimmer Biomet
  • Boston Scientific Corporation
  • Cochlear Ltd.
  • Edwards Lifesciences Corporation
  • Ekso Bionics
  • Medtronic
  • Jarvik Heart, Inc
  • SynCardia Systems, LLC.

第18章 免責聲明

簡介目錄
Product Code: UMHE212512

Artificial organs and bionic implants are revolutionary technologies that aim to restore or enhance the functionality of a specific organ or system in the human body. These advancements have the potential to significantly improve the quality of life for individuals with organ failure, disability, or degenerative diseases. For Instance, as per the data of Organ Procurement & Transplantation Network, in year 2021, 41,354 organ transplants were performed in the United States, an increase of 5.9 percent over 2020. The demand for artificial organs and bionic implants arises from the need to replace or support the functioning of damaged or non-functional organs. the increasing prevalence of chronic diseases, technological advancements, the aging population, growing awareness, and supportive policies have collectively acted as significant drivers for the Artificial Organs & Bionic Implants market.

Artificial Organs and Bionic Implants Market was valued at USD 35,000 Million in 2022 and is expected to grow at a CAGR of around 10% from 2023-2030.

Based on the Type, the market is segmented into artificial organs and Bionics. The artificial organs category hold considerable share of the market in 2022. The segment is experiencing growth primarily due to the increasing demand for kidney, heart, lung, and liver transplants. For Instance, as per the data of Organ Procurement & Transplantation Network, there were totals of 24,669 kidney transplants, 9,236 liver transplants and 3,817 heart transplants in US. In the United States, the average median waiting time for a kidney transplant is approximately 5 years. Consequently, manufacturers have been motivated to address the challenge of meeting the unmet demand by developing innovative solutions such as bio-lungs, artificial pancreas, and wearable artificial kidneys.

Based on Technology, the market is categorized into Mechanical and Electronic. Among these, the Mechanical category held a significant share of the market in 2022. Mechanical artificial organs can be used to assist individuals with congenital disabilities or birth defects. For instance, a prosthetic device can help someone with a missing hand to perform daily tasks and lead a more independent life.

For a better understanding of the market adoption of the industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, UK, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia-Pacific), Rest of World. North America held dominating share of Peripheral Pulse Oximeters Market in 2022. The presence of well-established healthcare infrastructure, along with the increasing healthcare expenditure in the countries is the major attributing factor for the market growth in North America.

Some of the major players operating in the market include: ABIOMED; Berlin Heart; Zimmer Biomet; Boston Scientific Corporation; Cochlear Ltd.; Edwards Lifesciences Corporation; Ekso Bionics; Medtronic; Jarvik Heart, Inc; and SynCardia Systems, LLC. etc.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Artificial Organs & Bionic Implants Market
  • 2.2. Research Methodology of the Artificial Organs & Bionic Implants Market
  • 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL ARTIFICIAL ORGANS & BIONIC IMPLANTS MARKET

6 MARKET COVID-19 IMPACT

7 GLOBAL ARTIFICIAL ORGANS & BIONIC IMPLANTS MARKET REVENUE, 2020-2030F

8 MARKET INSIGHTS BY TYPE

  • 8.1. Artificial Organ
    • 8.1.1. Artificial Heart
    • 8.1.2. Artificial Kidney
    • 8.1.3. Artificial Lungs
    • 8.1.4. Cochlear Implants
    • 8.1.5. Other Organ Types
  • 8.2. Bionics
    • 8.2.1. Vision Bionics
    • 8.2.2. Ear Bionics
    • 8.2.3. Orthopedic Bionic
    • 8.2.4. Other Bionics

9 MARKET INSIGHTS BY TECHNOLOGY

  • 9.1. Mechanical
  • 9.2. Electronic

10 MARKET INSIGHTS BY REGION

  • 10.1. North America Artificial Organs & Bionic Implants Market
    • 10.1.1. U.S.
    • 10.1.2. Canada
    • 10.1.3. Rest of North America
  • 10.2. Europe Artificial Organs & Bionic Implants Market
    • 10.2.1. Germany
    • 10.2.2. UK
    • 10.2.3. France
    • 10.2.4. Italy
    • 10.2.5. Spain
    • 10.2.6. Rest of Europe
  • 10.3. Asia-Pacific Artificial Organs & Bionic Implants Market
    • 10.3.1. China
    • 10.3.2. Japan
    • 10.3.3. India
    • 10.3.4. Rest of APAC
  • 10.4. Rest of the World Artificial Organs & Bionic Implants Market

11 ARTIFICIAL ORGANS & BIONIC IMPLANTS MARKET DYNAMICS

  • 11.1. Market Drivers
  • 11.2. Market Challenges
  • 11.3. Impact Analysis

12 ARTIFICIAL ORGANS & BIONIC IMPLANTS MARKET OPPORTUNITIES

13 ARTIFICIAL ORGANS & BIONIC IMPLANTS MARKET TRENDS

14 DEMAND AND SUPPLY-SIDE ANALYSIS

  • 14.1. Demand Side Analysis
  • 14.2. Supply Side Analysis

15 VALUE CHAIN ANALYSIS

16 COMPETITIVE SCENARIO

  • 16.1. Competitive Landscape
    • 16.1.1. Porters Fiver Forces Analysis

17 COMPANY PROFILED

  • 17.1. ABIOMED
  • 17.2. Berlin Heart
  • 17.3. Zimmer Biomet
  • 17.4. Boston Scientific Corporation
  • 17.5. Cochlear Ltd.
  • 17.6. Edwards Lifesciences Corporation
  • 17.7. Ekso Bionics
  • 17.8. Medtronic
  • 17.9. Jarvik Heart, Inc
  • 17.10. SynCardia Systems, LLC.

18 DISCLAIMER